表紙
市場調査レポート

D. Western Therapeutics Institute, Inc.:製品パイプライン分析

D. Western Therapeutics Institute, Inc. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 251660
出版日 ページ情報 英文 27 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
D. Western Therapeutics Institute, Inc.:製品パイプライン分析 D. Western Therapeutics Institute, Inc. - Product Pipeline Review - 2015
出版日: 2015年08月26日 ページ情報: 英文 27 Pages
概要

D. Western Therapeutics Institute, Inc.は新薬の開発に取り組んでいる製薬会社であり、同社の製品は閉塞性動脈硬化症、緑内障、高血圧症などの治療薬に使われており、抗癌剤も製造しています。

当レポートではD. Western Therapeutics Institute, Inc.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

D. Western Therapeutics Institute, Inc.の基本情報

D. Western Therapeutics Institute, Inc.の概要

  • 主要情報
  • 企業情報

D. Western Therapeutics Institute, Inc.:R&Dの概要

  • 主な治療範囲

D. Western Therapeutics Institute, Inc.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • アウトライセンス製品
    • アウトライセンス製品/併用療法モダリティ

D. Western Therapeutics Institute, Inc.:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

D. Western Therapeutics Institute, Inc.:薬剤プロファイル

  • H-1129
  • H-1129 Backup
  • Small Molecule for Cardiovascular System
  • Small Molecule for Central Nervous System Disorders
  • Small Molecule for Ophthalmology
  • Small Molecule for Respiratory System

D. Western Therapeutics Institute, Inc.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

D. Western Therapeutics Institute, Inc.:休止中のプロジェクト

D. Western Therapeutics Institute, Inc.:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07447CDB

Summary

Global Markets Direct's, 'D. Western Therapeutics Institute, Inc. - Product Pipeline Review - 2015', provides an overview of the D. Western Therapeutics Institute, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of D. Western Therapeutics Institute, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of D. Western Therapeutics Institute, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of D. Western Therapeutics Institute, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the D. Western Therapeutics Institute, Inc.'s pipeline products

Reasons to buy

  • Evaluate D. Western Therapeutics Institute, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of D. Western Therapeutics Institute, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the D. Western Therapeutics Institute, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of D. Western Therapeutics Institute, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of D. Western Therapeutics Institute, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of D. Western Therapeutics Institute, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • D. Western Therapeutics Institute, Inc. Snapshot
    • D. Western Therapeutics Institute, Inc. Overview
    • Key Information
    • Key Facts
  • D. Western Therapeutics Institute, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • D. Western Therapeutics Institute, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • D. Western Therapeutics Institute, Inc. - Pipeline Products Glance
    • D. Western Therapeutics Institute, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • D. Western Therapeutics Institute, Inc. - Drug Profiles
    • H-1129
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • H-1129 Backup
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Cardiovascular System
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Central Nervous System Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Ophthalmology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Respiratory System
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • D. Western Therapeutics Institute, Inc. - Pipeline Analysis
  • D. Western Therapeutics Institute, Inc. - Pipeline Products by Target
  • D. Western Therapeutics Institute, Inc. - Pipeline Products by Route of Administration
  • D. Western Therapeutics Institute, Inc. - Pipeline Products by Molecule Type
  • D. Western Therapeutics Institute, Inc. - Pipeline Products by Mechanism of Action
  • D. Western Therapeutics Institute, Inc. - Dormant Projects
  • D. Western Therapeutics Institute, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • D. Western Therapeutics Institute, Inc., Key Information
  • D. Western Therapeutics Institute, Inc., Key Facts
  • D. Western Therapeutics Institute, Inc. - Pipeline by Indication, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline by Stage of Development, 2015
  • D. Western Therapeutics Institute, Inc. - Monotherapy Products in Pipeline, 2015
  • D. Western Therapeutics Institute, Inc. - Out-Licensed Products in Pipeline, 2015
  • D. Western Therapeutics Institute, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • D. Western Therapeutics Institute, Inc. - Preclinical, 2015
  • D. Western Therapeutics Institute, Inc. - Discovery, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline by Target, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline by Route of Administration, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline by Molecule Type, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline Products by Mechanism of Action, 2015
  • D. Western Therapeutics Institute, Inc. - Dormant Developmental Projects,2015
  • D. Western Therapeutics Institute, Inc., Other Locations

List of Figures

  • D. Western Therapeutics Institute, Inc. - Pipeline by Top 10 Indication, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline by Stage of Development, 2015
  • D. Western Therapeutics Institute, Inc. - Monotherapy Products in Pipeline, 2015
  • D. Western Therapeutics Institute, Inc. - Out-Licensed Products in Pipeline, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline by Top 10 Target, 2015
  • D. Western Therapeutics Institute, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top